-
Risk in the AirAir pollution can increase a person's risk of developing cancer, a burden that isn't shared equally in every neighborhood.
by Jon Kelvey
-
Practical Considerations for CannabisPeople with cancer who are thinking about using cannabis to manage cancer-related symptoms should seek answers to some practical questions.
by Kate Yandell
-
An Emerging Treatment for Metastatic Prostate CancerA drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.
by Pamela Rafalow Grossman
-
Exercise, Cancer and AgingA study on aging shows that cancer survivors are at higher risk of losing strength and walking more slowly compared to those with no cancer history. Exercise is one way to combat this decline.
by Marcus A. Banks
-
Preconceived Notions: Cancer, Fertility Coverage and the LawInsurance coverage for fertility treatments is not mandated by federal law, although some states require it. People seeking cancer treatment need to understand their coverage and the law in their state.
by Shelly Rosenfeld
-
Drug Delays Recurrence in People With Early-Stage Breast CancerPeople who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.
by Pamela Rafalow Grossman
-
Open Medical Records: Pros and ConsPatients now have full access to their online medical records. What are the benefits and downsides?
by Jen Tota McGivney
-
Remote CareAfter adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs' value for cancer patients undergoing treatment.
by Jon Kelvey
-
Moving Away From the Maximum Tolerated DoseThe FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
-
The Individual Sphere of InfluenceCan discussion of health inequities lead to actionable change?
by Marci A. Landsmann
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
